• AP20187: Precision Dimerization in Translational Oncology

  2026-06-23

  This thought-leadership article explores how AP20187, a synthetic chemical inducer of dimerization, advances the frontiers of conditional gene therapy and regulated cell therapies in oncology. By integrating mechanistic insights and translational guidance, we highlight AP20187's pivotal role in modulating tumor microenvironment signaling, building on recent discoveries in cancer-associated fibroblast biology and offering strategic recommendations for researchers targeting complex cellular networks.

• TRPV1+ Nerve Stimulation Suppresses Inflammation via Reflex

  2026-06-23

  Song et al. (2025) elucidate how targeted stimulation of TRPV1-expressing peripheral somatosensory nerves, using a capsaicin analog such as Nonivamide, activates a neural reflex that rapidly reduces systemic inflammation. Their findings clarify the neuroimmune mechanisms underlying this effect and open new pathways for translational research into anti-inflammatory interventions.

• Elobixibat Hydrate: Mechanistic Advances in Chronic Constipa

  2026-06-22

  Acosta and Camilleri's review introduces elobixibat as a selective ileal bile acid transporter inhibitor with a novel mechanism for treating chronic idiopathic constipation. Their work elucidates how modulating enterohepatic bile acid circulation can improve colonic motility and secretion, representing a significant translational advance for gastrointestinal research and therapy.

• Sumatriptan Succinate: 5-HT1 Receptor Agonist in Lab & Clini

  2026-06-22

  Sumatriptan Succinate excels as a selective 5-HT1 receptor agonist for both translational migraine research and neuroinflammation models. Discover advanced workflows, pediatric ED findings, and actionable troubleshooting tips that set this compound apart for serotonergic signaling studies.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus: Enabli

  2026-06-21

  Explore how the HyperScribe Co-transcription mRNA Synthesis Kit Plus empowers efficient ARCA capped mRNA synthesis with stable poly(A) tails, facilitating next-generation RNA vaccine development and functional mRNA studies. This article uniquely details protocol optimization and the translational impact of mRNA engineering breakthroughs.

• Etoposide (VP-16): Nanotechnology-Driven Cancer Assay Revolu

  2026-06-20

  Explore how Etoposide (VP-16) is transforming cancer chemotherapy research through advanced nanotechnology and localized delivery strategies. This in-depth analysis reveals unique assay design insights and practical parameters for maximizing DNA damage and apoptosis induction in cancer cells.

• Optimizing Fluorescent RNA Probes with HyperScribe™ T7 Cy5 K

  2026-06-19

  This article examines practical laboratory challenges in fluorescent RNA probe synthesis and showcases how the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit (SKU K1062) enables reproducible, sensitive probe preparation. Supported by recent literature and real-world scenarios, it provides actionable guidance for researchers seeking validated workflows for in situ hybridization, Northern blotting, and beyond.

• Triple Color Protein Ladders: Accelerating Discovery in Tran

  2026-06-19

  Explore how mechanistic insight into ribotoxic stress and advanced protein size standards unify to empower translational researchers. This article bridges recent findings on UV-mediated cell death and the evolving needs in protein analysis, highlighting the translational impact of APExBIO's Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa).

• Metronidazole: OAT3 Inhibition & Anaerobic Targeting in Rese

  2026-06-18

  Metronidazole, or 2-(2-methyl-5-nitroimidazol-1-yl)ethanol, is a nitroimidazole antibiotic and a potent OAT3 inhibitor. It enables precision in transporter-mediated drug interaction studies and is widely used for targeting anaerobic bacteria and protozoa. Its high purity and well-characterized inhibition kinetics make it a benchmark tool for drug-drug interaction and microbiota research.

• 2'3'-cGAMP (sodium salt): Decoding cGAS-STING in Brain Injur

  2026-06-18

  Discover how 2'3'-cGAMP (sodium salt) enables advanced research into STING-mediated innate immune response, focusing on neuroinflammation and surgical brain injury models. This article offers unique insights and practical guidance beyond standard immunotherapy applications.

• MLN4924 HCl Salt: Selective NEDD8-Activating Enzyme Inhibito

  2026-06-17

  MLN4924 HCl salt is a selective NEDD8-activating enzyme inhibitor widely used in cancer biology and cell cycle research. By blocking the neddylation pathway, it enables precise interrogation of protein degradation mechanisms. APExBIO’s A3629 product is benchmarked for reproducibility and high purity in advanced workflows.

• Etoposide and Topotecan in First-Line Small Cell Lung Cancer

  2026-06-17

  This article examines the pivotal role of etoposide (VP-16) and topotecan in first-line therapy for small cell lung cancer (SCLC), focusing on recent clinical findings and their implications for cancer chemotherapy research. By analyzing innovations and comparative efficacy from a landmark study, it provides technical insights for researchers seeking to optimize DNA damage and apoptosis assays.

• Neuroinflammatory CGRP/SP-Piezo2 Axis in Trigeminal Allodyni

  2026-06-16

  Liao et al. reveal how trigeminal nerve root compression drives mechanical allodynia through a neuroinflammatory CGRP/SP-Piezo2 axis, mediated by Ca2+-dependent signaling. These findings clarify a key mechanism of peripheral sensitization in trigeminal neuralgia, offering new experimental targets for pain and inflammation research.

• Hemagglutinin mRNA Vaccine Protects Dairy Cows Against H5N1

  2026-06-16

  This study demonstrates the robust protective efficacy of a hemagglutinin-based mRNA vaccine against H5N1 influenza in lactating dairy cows. Its findings support the feasibility of mRNA vaccines for controlling emerging zoonotic threats in livestock and highlight the importance of durable immunity, even as antibody levels wane.

• AI-10-49: A Selective CBFβ-SMMHC Inhibitor in AML Research

  2026-06-15

  AI-10-49 stands out as a powerful tool for dissecting the oncogenic CBFβ-SMMHC fusion axis in acute myeloid leukemia. Its specificity enables researchers to restore RUNX1 activity and interrogate the N-MYC/eIF4G1 pathway, accelerating both mechanistic and translational leukemia studies.

16472 records 1/1099 page Next 12345 下5页 Last page